Development of non-invasive method for the detection of mutated circulating nuclear acid

Development of non-invasive method for the detection of mutated circulating nuclear acid - Development of non-invasive method for the detection of mutated circulating nuclear acid

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011814

Enrollment

300

Registered

2013-09-19

Start date

2013-09-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer Colon cancer Hepatocellar carcinoma Gastric cancer Bile duct cancer Inflammatory bowel disease (Ulcerative colitis, Crohn) Intraductal papillary mucinous neoplasm Autoimmune disease Hepatic/ digestive tract disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients for whom examination for hepatic /digestive tract disorder is selected in clinical practice 2)Patients who have provided written informed consent for participation in this study

Exclusion criteria

Exclusion criteria: Patients judged by the principal investigator or subinvestigator to be unsuitable for participation for any other reason (to ensure the safe conduct of this study)

Design outcomes

Primary

Measure	Time frame
Detection rate of rare mutation	—

Secondary

Measure	Time frame
Overall survival (OS) Progression free survival (PFS) Tumor marker assessment	—

Countries

Japan

Contacts

Public ContactHIDEAKI KINUGASA

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. GASTROENTEROLOGY

gyacy14@gmail.com086-235-7218

Outcome results